Trial Profile
US phase II trial of an encapsulated cell therapy product [NovaCaps] for pain due to advanced, inoperable pancreatic cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2019
Price :
$35
*
At a glance
- Drugs Microencapsulated CYP2B1-expressing cells+ifosfamide PharmaCyte Biotech (Primary) ; Ifosfamide
- Indications Pain; Pancreatic cancer
- Focus Therapeutic Use
- 04 Nov 2019 According to a PharmaCyte Biotech media release, the company is closer to submitting an Investigational New Drug application (IND) to the U.S. Food & Drug Administration (FDA).
- 16 Apr 2014 New trial record